Cystic fibrosis Delta F508 heterozygotes, smoking, and reproduction: studies of 9141 individuals from a general population sample
- PMID: 9628826
- DOI: 10.1006/geno.1998.5272
Cystic fibrosis Delta F508 heterozygotes, smoking, and reproduction: studies of 9141 individuals from a general population sample
Abstract
Cystic fibrosis is the most common fatal autosomal recessive disease affecting Caucasian populations. It remains a puzzle how this disease is maintained at such a remarkably high incidence, however, it could be due to a reproductive advantage in cystic fibrosis heterozygotes. We tested this hypothesis. An adult Danish general population sample of 9141 individuals was screened for cystic fibrosis DeltaF508 heterozygotes; 250 carriers of this mutation were identified (2.7%). In the total sample DeltaF508 heterozygotes did not have more children than noncarriers; however, smoking interacted with genotype in predicting number of children (ANOVA: P < 0.001). Among nonsmokers, heterozygotes had more children than noncarriers (Wilcoxon: P = 0.03). Among smokers, the opposite was found: heterozygotes had fewer children than noncarriers (Wilcoxon: P = 0. 001). These findings remained significant after allowing for gender and the potential confounders of age, income, and education. Finally, after allowing for these covariates, number of children in DeltaF508 heterozygotes decreased with increasing extent of smoking (trend test: P = 0.003), while the opposite was true for noncarriers (trend test: P < 0.001). In conclusion, overall these results do not support a reproductive advantage for cystic fibrosis DeltaF508 heterozygotes. However, the data cannot totally exclude the possibility that nonsmoking DeltaF508 heterozygotes experience a reproductive advantage while smoking DeltaF508 heterozygotes experience the opposite, a reproductive disadvantage. Accordingly, the data suggest a previously undocumented role of smoking on fecundity among cystic fibrosis heterozygotes.
Copyright 1998 Academic Press.
Similar articles
-
Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion.J Allergy Clin Immunol. 2001 May;107(5):818-23. doi: 10.1067/mai.2001.114117. J Allergy Clin Immunol. 2001. PMID: 11344348
-
No association between the deltaF508 cystic fibrosis mutation and type 2 diabetes mellitus.Exp Clin Endocrinol Diabetes. 1999;107(8):568-9. doi: 10.1055/s-0029-1232567. Exp Clin Endocrinol Diabetes. 1999. PMID: 10612489
-
[Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].Pol Merkur Lekarski. 2005 Feb;18(104):205-9. Pol Merkur Lekarski. 2005. PMID: 17877132 Polish.
-
Reproductive health in young people with cystic fibrosis.Curr Opin Pediatr. 1995 Aug;7(4):376-80. doi: 10.1097/00008480-199508000-00006. Curr Opin Pediatr. 1995. PMID: 7581639 Review.
-
Cystic fibrosis in adulthood.Tex Med. 1967 Jul;63(7):52-6. Tex Med. 1967. PMID: 5343170 Review. No abstract available.
Cited by
-
Identification and selection of healthy spermatozoa in heterozygous carriers of the Phe508del-variant of the CFTR-gene in assisted reproduction.Sci Rep. 2022 Feb 3;12(1):1866. doi: 10.1038/s41598-022-05925-1. Sci Rep. 2022. PMID: 35115637 Free PMC article.
-
Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyond.Eur Respir J. 2023 Apr 1;61(4):2201307. doi: 10.1183/13993003.01307-2022. Print 2023 Apr. Eur Respir J. 2023. PMID: 37003609 Free PMC article. Review.
-
Lung infections associated with cystic fibrosis.Clin Microbiol Rev. 2002 Apr;15(2):194-222. doi: 10.1128/CMR.15.2.194-222.2002. Clin Microbiol Rev. 2002. PMID: 11932230 Free PMC article. Review.
-
Markers of early disease and prognosis in COPD.Int J Chron Obstruct Pulmon Dis. 2009;4:157-67. doi: 10.2147/copd.s3106. Epub 2009 Apr 15. Int J Chron Obstruct Pulmon Dis. 2009. PMID: 19436688 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical